Results 91 to 100 of about 2,198,324 (297)

Translating whole‐genome doubling into precision medicine in cancer

Molecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source

The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer [PDF]

, 2002
Background: In sporadic ovarian cancer, we have previously reported allele loss at D6S193 (62%) on chromosome 6q27, which suggested the presence of a putative tumour suppressor gene.
Liu, Y, Phillippa Dodds, Charnock, FML, Dodds, P, Dunham Ian, Liu Ying, Wells R Spencer, Gracy Emilion, Ganesan Trivadi S, Beck, Stephan, Charnock, F Mark L, Emilion, G, Stephan Beck, Mungall, Andrew J, Ian Dunham, F Mark L Charnock, Wells, RS, Ganesan, TS, Emilion, Gracy, Dunham, I, Dodds Phillippa, Beck Stephan, Emilion Gracy, Wells, R Spencer, Dunham, Ian, Mungall Andrew J, Andrew J Mungall, Ying Liu, R Spencer Wells, Beck, S, Liu, Ying, Mungall, AJ, Trivadi S Ganesan, Charnock F Mark L, Dodds, Phillippa, Ganesan, Trivadi S   +35 more
core   +1 more source

The effects of anti-IL-6 therapy in advanced ovarian cancer [PDF]

, 2010
PhDIL-6 is a pleiotropic cytokine that has a significant role in inflammatory processes. In relation to ovarian cancer biology there is emerging evidence that it mediates processes relating to tumour growth, invasion, angiogenesis and chemo-resistance ...
Coward, Jermaine
core   +1 more source

Changes in Rehmanniae Radix processing and their impact on ovarian hypofunction: potential mechanisms of action

Frontiers in Pharmacology
ObjectiveThis study evaluates the research developments concerning Rehmanniae Radix in ovarian hypofunction diseases. It explores the processing methods of Rehmanniae Radix, the variations in its compounds before and after processing, the mechanism of ...
Han-Zhi Zhong, Jing Mo, Yan-Xin Li, Mao-Ya Li, Shao-Bin Wei   +4 more
doaj   +1 more source

CASE OF COMPLICATED OVARIAN DISEASE. [PDF]

The Lancet
n ...
openaire   +2 more sources

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source

Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors [PDF]

, 2009
Background: The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT).
Linda Hertlein, Klaus Friese, Dorothea Nagel, Mayr, Doris, Alexander Burges, Stieber, Petra, Nehring, Stefanie, Kirschenhofer, Angela, Miriam S. Lenhard, Angela Kirschenhofer, Friese, Klaus, Burges, Alexander, Doris Mayr, Lenhard, Miriam S., Hertlein, Linda, Nagel, Dorothea, Stefanie Nehring, Petra Stieber   +17 more
core   +2 more sources

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Tumour-associated immune responses and isolated carcinoembryonic antigen and alpha feto-protein levels related to survival in ovarian cancer patients. [PDF]

, 1976
The presence of a tumour-associated immune response in 37 patients with ovarian cancer as assessed by blastogenesis (lymphocyte transformation) evoked by ovarian cancer cell extracts, has been correlated with survival following the test.
Levin, L, Neville, AM, Hudson, CN, Poulton, TA, McHardy, JE, Kitau, MJ, Curling, OM   +6 more
core   +2 more sources

Cancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies

Molecular Oncology, EarlyView.
The cell‐autonomous roles of interferon type 1 vary based on duration and intensity. While acute, robust signaling results in cancer cell cytotoxic effects, sustained, low‐level signaling is associated with tumor‐promoting effects. This review summarizes current research of IFN‐1 in cancer and within the clinical setting, with an emphasis on female ...
Ashlyn Conant, Nora Badiner, Sharon Asariah, Kiera McGivney, Vishwa Shah, Tise Suzuki, Yevgeniya J. Ioffe, Juli J. Unternaehrer   +7 more
wiley   +1 more source